Contact Us
Schwab Client Login
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ping An Biomedical Co., Ltd. - Class A Ordinary Shares (NQ:PASW)

1.410 -0.180 (-11.32%)
Delayed Quote Updated: 11:22 AM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Ping An Biomedical Co., Ltd. - Class A Ordinary Shares

News headline image
Ping An Biomedical Enters into Patent Purchase Agreement with Future Biotechnology Group for Tumor Cell Technologies
The patent acquisition is intended to support the Company’s longer-term healthcare and biomedical research and development strategy. Separately, the Company continues to advance negotiations regarding... 
From Ping An Biomedical Co., Ltd
Via GlobeNewswire
News headline image
Ping An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property Portfolio
From Ping An Biomedical Co., Ltd
Via GlobeNewswire
News headline image
Ping An Biomedical Announces 1-for-40 Reverse Stock Split
Class A Ordinary Shares Expected to Begin Trading on a Split-Adjusted Basis on October 23, 2026 
From Ping An Biomedical Co., Ltd
Via GlobeNewswire
News headline image
IGC Pharma (NYSE: IGC) Target Raised on Alzheimer’s 2027 Outlook
Via AB Newswire
Topics Artificial Intelligence
News headline image
Ping An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting RMB 500 Million in Sales Over Three Years
From Ping An Biomedical Co., Ltd
Via GlobeNewswire
News headline image
All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital
From Ping An Biomedical Co., Ltd
Via GlobeNewswire
News headline image
ADM Endeavors (OTCQB: ADMQ) Reports $5.3M Revenue, Expands Operations Supporting 2026 Expansion Alongside EVTV, PASW, BMXI, UP, PNPNF
Via AB Newswire
News headline image
Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry
From Ping An Biomedical Co., Ltd.
Via GlobeNewswire
News headline image
Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation
From Ping An Biomedical Co., Ltd.
Via GlobeNewswire
News headline image
Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter
From Ping An Biomedical Co., Ltd.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.